New Pharmacotherapies in Chronic Lymphocytic Leukemia. - Wikidata - awgldk - TriplyDB

New Pharmacotherapies in Chronic Lymphocytic Leukemia.

New Pharmacotherapies in Chronic Lymphocytic Leukemia.

http://www.wikidata.org/entity/Q37605306

about

New Pharmacotherapies in Chronic Lymphocytic Leukemia.

http://www.wikidata.org/entity/Q37605306

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New Pharmacotherapies in Chronic Lymphocytic Leukemia.

@en

New Pharmacotherapies in Chronic Lymphocytic Leukemia.

@nl

type

label

New Pharmacotherapies in Chronic Lymphocytic Leukemia.

@en

New Pharmacotherapies in Chronic Lymphocytic Leukemia.

@nl

prefLabel

New Pharmacotherapies in Chronic Lymphocytic Leukemia.

@en

New Pharmacotherapies in Chronic Lymphocytic Leukemia.

@nl

P1433

Q37605306-DF78E707-F9C2-4A2C-B1BC-2E82873940F0

P1476

Q37605306-7C9B0C93-558B-449E-958B-317A12C0316E

P2093

Q37605306-13055CDE-A327-41FF-9A41-9ED8B6982D52

Q37605306-495FAF75-185A-41D5-9C48-09CA168561AB

Q37605306-5C0B45CD-385A-4684-B9C8-8029CF4A3D28

P2860

Q37605306-05AE98FC-B736-4596-8B3D-EB6105D05029

Q37605306-07B88E62-72C7-413D-9EAD-2FBFF607F82F

Q37605306-0A5B957E-AF95-4319-A3B2-06C3E5C64267

Q37605306-149C189C-D665-4CB9-AA15-D24421644635

Q37605306-1E747C66-2D06-4989-8E78-4CD25AFB6E55

Q37605306-20BBAAA5-EDD5-4105-AED2-A0D36EF4DB07

Q37605306-230D49EF-3CD1-4334-87E5-B23FBCAFF009

Q37605306-2B67560F-B33E-414E-BA49-97B3F90B868B

Q37605306-2BB00167-07A5-42E9-B99A-4D44CB89ECAE

Q37605306-3058A5C2-90AE-4331-9EDC-91C638B54C93

P304

Q37605306-DDFA97BA-987A-4E64-BD12-DC8460DE22F1

P31

Q37605306-5B53B910-AD2F-4357-8C66-E993C7340C33

P433

Q37605306-9FBFCD77-4780-44FB-B569-AE154DF15F02

P478

Q37605306-48CE63C9-A5A8-484B-BFD2-38BDEF0066AC

P577

Q37605306-92F510F0-3435-4ADA-996A-AF1909101ED4

P698

Q37605306-139A9A09-0730-4513-B203-399C4257B94E

P921

Q37605306-88C23B3C-F12C-4E1E-BECC-12746DF4FEA1

Q37605306-E746245B-D016-4F92-B925-BC21D53DDFD8

P932

Q37605306-40083B21-AE7C-468E-8E05-8BEC88E1CA2A

P1433

P & T: journal for formulary management

P1476

New Pharmacotherapies in Chronic Lymphocytic Leukemia.

@en

P2093

Jacqueline L Olin

http://www.w3.org/2001/XMLSchema#string

Katherine Canupp

http://www.w3.org/2001/XMLSchema#string

Morgan B Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

Manufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapies

Genomic aberrations and survival in chronic lymphocytic leukemia

PI3K in lymphocyte development, differentiation and activation

Idelalisib and rituximab in relapsed chronic lymphocytic leukemia

Cancer statistics, 2016

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia

P304

106-115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28163556

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy

P932

5265236

http://www.w3.org/2001/XMLSchema#string